Development
Ultralife Corporation
ULBI
$7.70
-$0.155-1.98%
NASDAQ
| 09/30/2023 | 06/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -7.50% | 33.76% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -7.50% | 33.76% | |||
| Cost of Revenue | -7.44% | 31.14% | |||
| Gross Profit | -7.69% | 42.39% | |||
| SG&A Expenses | 12.15% | -4.33% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.29% | 22.38% | |||
| Operating Income | -41.75% | 13,996.15% | |||
| Income Before Tax | -62.97% | 1,109.19% | |||
| Income Tax Expenses | -67.56% | 1,133.83% | |||
| Earnings from Continuing Operations | -61.08% | 1,099.40% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 437.50% | 27.27% | |||
| Net Income | -60.18% | 1,065.32% | |||
| EBIT | -41.75% | 13,996.15% | |||
| EBITDA | -32.89% | 366.60% | |||
| EPS Basic | -60.42% | 1,066.82% | |||
| Normalized Basic EPS | -62.17% | 1,070.21% | |||
| EPS Diluted | -61.33% | 1,066.82% | |||
| Normalized Diluted EPS | -62.34% | 1,070.21% | |||
| Average Basic Shares Outstanding | 0.60% | 0.03% | |||
| Average Diluted Shares Outstanding | 0.99% | 0.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||